4.3 Article

Escherichia coli virulence factors

Journal

VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY
Volume 152, Issue 1-2, Pages 2-12

Publisher

ELSEVIER
DOI: 10.1016/j.vetimm.2012.09.032

Keywords

Escherichia coli; Virulence; Adhesins; Type 3 secretion system; Toxins

Funding

  1. Institut pour l'encouragement de la Recherche Scientifique dans l'Industrie et l'Agriculture (IRSIA)
  2. Ministere des Classes moyennes et de l'Agriculture DGVI
  3. Service public federal de Sante publique, Securite de la Chaine alimentaire et Environnement at the Belgian federal level
  4. Fonds National de la Recherche scientifique
  5. Conseil de la Recherche de l'Universite de Liege at the regional level
  6. European Commission at the European level

Ask authors/readers for more resources

Escherichia coli was described in 1885 by a German pediatrician, Theodor Escherich, in the faeces of a child suffering diarrhoea. In 1893, a Danish veterinarian postulated that the E. con species comprises different strains, some being pathogens, others not. Today the E. coli species is subdivided into several pathogenic strains causing different intestinal, urinary tract or internal infections and pathologies, in animal species and in humans. Since this congress topic is the interaction between E. coli and the mucosal immune system, the purpose of this manuscript is to present different classes of adhesins (fimbrial adhesins, afimbrial adhesins and outer membrane proteins), the type 3 secretion system, and some toxins (oligopeptide, AB, and RTX pore-forming toxins) produced by E. coli, that can directly interact with the epithelial cells of the intestinal, respiratory and urinary tracts. (C) 2012 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available